Management of Outpatient Hemodialysis During the COVID-19 Pandemic: Recommendations From the Canadian Society of Nephrology COVID-19 Rapid Response Team.

clinical guidelines hemodialysis infectious diseases

Journal

Canadian journal of kidney health and disease
ISSN: 2054-3581
Titre abrégé: Can J Kidney Health Dis
Pays: England
ID NLM: 101640242

Informations de publication

Date de publication:
2020
Historique:
received: 17 04 2020
accepted: 04 06 2020
entrez: 23 9 2020
pubmed: 24 9 2020
medline: 24 9 2020
Statut: epublish

Résumé

To collate best practice recommendations on the management of patients receiving in-center hemodialysis during the COVID-19 pandemic, based on published reports and current public health advice, while considering ethical principles and the unique circumstances of Canadian hemodialysis units across the country. The workgroup members used Internet search engines to retrieve documents from provincial and local hemodialysis programs; provincial public health agencies; the Centers for Disease Control and Prevention; webinars and slides from other kidney agencies; and nonreviewed preprints. PubMed was used to search for peer-reviewed published articles. Informal input was sought from knowledge users during a webinar. Challenges in the care of hemodialysis patients during the COVID-19 pandemic were highlighted within the Canadian Senior Renal Leaders Forum discussion group. The Canadian Society of Nephrology (CSN) developed the COVID-19 rapid response team (RRT) to address these challenges. They identified a pan-Canadian team of clinicians and administrators with expertise in hemodialysis to form the workgroup. One lead was chosen who drafted the initial document. Members of the workgroup reviewed and discussed all recommendations in detail during 2 virtual meetings on April 7 and April 9. Disagreements were resolved by consensus. The document was reviewed by the CSN COVID-19 RRT, an ethicist, an infection control expert, a community nephrologist, and a patient partner. Content was presented during an interactive webinar on April 11, 2020 attended by 269 kidney health professionals, and the webinar and first draft of the document were posted online. Final revisions were made based on feedback received until April 13, 2020. CJKHD editors reviewed the parallel process peer review and edited the manuscript for clarity. Recommendations were made under the following themes: (1) Identification of patients with COVID-19 in the dialysis unit, (2) hemodialysis of patients with confirmed COVID-19, (3) hemodialysis of patients not yet known to have COVID-19, (4) visitors; (5) testing for COVID-19 in the dialysis unit; (6) resuscitation, (6) routine hemodialysis care, (7) hemodialysis care under fixed dialysis resources. Because of limitations of time and resources, and the large number of questions, formal systematic review was not undertaken. The recommendations are based on expert opinion and subject to bias. The parallel review process that was created may not be as robust as the standard peer review process. We hope that these recommendations provide guidance for dialysis unit directors, clinicians, and administrators on how to limit risk from infection and adverse outcomes, while providing necessary dialysis care in a setting of finite resources. We also identify a number of resource allocation priorities, which we hope will inform decisions at provincial funding agencies.

Identifiants

pubmed: 32963790
doi: 10.1177/2054358120938564
pii: 10.1177_2054358120938564
pmc: PMC7488889
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2054358120938564

Investigateurs

John Antonsen (J)
Cheryl Banks (C)
David Clark (D)
Edward Clark (E)
Michael Copland (M)
Sara N Davison (SN)
Aviva Goldberg (A)
Juliya Hemmett (J)
Swapnil Hiremath (S)
Joanne Kappel (J)
Jennifer M MacRae (JM)
Fabrice Mac-Way (F)
Anna Mathew (A)
Brendan McCormick (B)
Louise Moist (L)
Sarah Moran (S)
Sanjay Pandeya (S)
Elena Qirjazi (E)
Krista Ryz (K)
Suneet Singh (S)
Steven Soroka (S)
Rita Suri (R)
Karthik Tennankore (K)
Susan Thanabalasingam (S)
Ron Wald (R)
Mathew Weir (M)
Christine White (C)
Deborah Zimmerman (D)
Adeera Levin (A)
Reem A Mustafa (RA)
Gihad Nesrallah (G)
Steven Soroka (S)
Deborah Zimmerman (D)

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Int Urol Nephrol. 2020 Jun;52(6):1193-1194
pubmed: 32222883
Am J Kidney Dis. 2014 Aug;64(2):181-6
pubmed: 24840669
Clin J Am Soc Nephrol. 2020 May 7;15(5):717-719
pubmed: 32241778
Nephrol Dial Transplant. 2020 May 1;35(5):737-741
pubmed: 32196116
Clin J Am Soc Nephrol. 2020 May 7;15(5):707-709
pubmed: 32198130
Am J Kidney Dis. 2016 Aug;68(2):256-265
pubmed: 26867814
Panminerva Med. 2017 Jun;59(2):188-196
pubmed: 28090764

Auteurs

Rita S Suri (RS)

Division of Nephrology, Department of Medicine/Research Institute, McGill University, Montreal, QC, Canada.
Centre de recherche de l'Université de Montréal, Montreal, QC, Canada.

John E Antonsen (JE)

Hemodialysis Committee, British Columbia Renal Agency, Vancouver, Canada.

Cheryl A Banks (CA)

Prince Edward Island Provincial Renal Program, Summerside, Canada.

David A Clark (DA)

Division of Nephrology, Department of Medicine, Dalhousie University & Nova Scotia Health Authority, Halifax, Canada.

Sara N Davison (SN)

Division of Nephrology, Department of Medicine, University of Alberta, Edmonton, Canada.

Charles H Frenette (CH)

Division of Infectious Diseases, Department of Medicine, McGill University, Montreal, QC, Canada.

Joanne E Kappel (JE)

Division of Nephrology, Department of Medicine, University of Saskatchewan, Saskatoon, Canada.

Jennifer M MacRae (JM)

Division of Nephrology, Department of Medicine, University of Calgary/Alberta Health Services, Canada.

Fabrice Mac-Way (F)

CHU de Québec Research Center, L'Hôtel-Dieu de Québec Hospital, Division of Nephrology, Department of Medicine, Université Laval, QC, Canada.

Anna Mathew (A)

Division of Nephrology, Department of Medicine, McMaster University, Hamilton, ON, Canada.

Louise M Moist (LM)

Division of Nephrology, Department of Medicine, Western University, London, ON, Canada.

Elena Qirjazi (E)

Division of Nephrology, Department of Medicine, University of Calgary/Alberta Health Services, Canada.

Karthik K Tennankore (KK)

Division of Nephrology, Department of Medicine, Dalhousie University & Nova Scotia Health Authority, Halifax, Canada.

Hans Vorster (H)

Ontario Renal Network, Toronto, Canada.

Classifications MeSH